{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "11",
                "@timestamp": "2022-06-11T07:04:38.000038-04:00",
                "@year": "2022",
                "@month": "06"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "03"
            }
        },
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "60018973",
                            "@country": "deu",
                            "city": "Bad Berka",
                            "organization": [
                                {"$": "Theranostics Center for Molecular Radiotherapy and Molecular Imaging"},
                                {"$": "Zentralklinik Bad Berka"}
                            ],
                            "affiliation-id": {
                                "@afid": "60018973",
                                "@dptid": "110029828"
                            },
                            "@affiliation-instance-id": "2017657573-13ec53603fa35861d1e24b3f7f693ceb",
                            "ce:source-text": "Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany",
                            "@dptid": "110029828"
                        },
                        "author": [
                            {
                                "ce:given-name": "Richard P.",
                                "preferred-name": {
                                    "ce:given-name": "Richard P.",
                                    "ce:initials": "R.P.",
                                    "ce:surname": "Baum",
                                    "ce:indexed-name": "Baum R.P."
                                },
                                "@author-instance-id": "2017657573-6caea5b81c36601baba006db90197893",
                                "@seq": "1",
                                "ce:initials": "R.P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Baum",
                                "@auid": "55579753600",
                                "ce:indexed-name": "Baum R.P."
                            },
                            {
                                "ce:given-name": "Christiane",
                                "preferred-name": {
                                    "ce:given-name": "Christiane",
                                    "ce:initials": "C.",
                                    "ce:surname": "Schuchardt",
                                    "ce:indexed-name": "Schuchardt C."
                                },
                                "@author-instance-id": "2017657573-59d8d4d12c1a431cd43f30c7ab4ebb08",
                                "@seq": "2",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Schuchardt",
                                "@auid": "16686933700",
                                "ce:indexed-name": "Schuchardt C."
                            },
                            {
                                "ce:given-name": "Aviral",
                                "preferred-name": {
                                    "ce:given-name": "Aviral",
                                    "ce:initials": "A.",
                                    "ce:surname": "Singh",
                                    "ce:indexed-name": "Singh A."
                                },
                                "@author-instance-id": "2017657573-9b6c771ae2fbcd394f6e21d862320ea3",
                                "@seq": "3",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Singh",
                                "@auid": "56576751100",
                                "ce:indexed-name": "Singh A."
                            },
                            {
                                "ce:given-name": "Maythinee",
                                "preferred-name": {
                                    "ce:given-name": "Maythinee",
                                    "ce:initials": "M.",
                                    "ce:surname": "Chantadisai",
                                    "ce:indexed-name": "Chantadisai M."
                                },
                                "@author-instance-id": "2017657573-6bc70175e7a487cb78329aaf3ecd9fc1",
                                "@seq": "4",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chantadisai",
                                "@auid": "56183484200",
                                "ce:indexed-name": "Chantadisai M."
                            },
                            {
                                "ce:given-name": "Franz C.",
                                "preferred-name": {
                                    "ce:given-name": "Franz C.",
                                    "ce:initials": "F.C.",
                                    "ce:surname": "Robiller",
                                    "ce:indexed-name": "Robiller F.C."
                                },
                                "@author-instance-id": "2017657573-3f9893daa4c8ff74a4aaca6ed9c0b113",
                                "@seq": "5",
                                "ce:initials": "F.C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Robiller",
                                "@auid": "56182602700",
                                "ce:indexed-name": "Robiller F.C."
                            },
                            {
                                "ce:given-name": "Jingjing",
                                "preferred-name": {
                                    "ce:given-name": "Jingjing",
                                    "ce:initials": "J.",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang J."
                                },
                                "@author-instance-id": "2017657573-2a97a5a0d7dc3db5d84705500dd9aa19",
                                "@seq": "6",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Zhang",
                                "@auid": "55565946700",
                                "ce:indexed-name": "Zhang J."
                            },
                            {
                                "ce:given-name": "Dirk",
                                "preferred-name": {
                                    "ce:given-name": "Dirk",
                                    "ce:initials": "D.",
                                    "ce:surname": "Mueller",
                                    "ce:indexed-name": "Mueller D."
                                },
                                "@author-instance-id": "2017657573-9170ee39b167eed394bc572aafb2f99f",
                                "@seq": "7",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Mueller",
                                "@auid": "37054494800",
                                "ce:indexed-name": "Mueller D."
                            },
                            {
                                "ce:given-name": "Alexander",
                                "preferred-name": {
                                    "ce:given-name": "Alexander",
                                    "ce:initials": "A.",
                                    "ce:surname": "Eismant",
                                    "ce:indexed-name": "Eismant A."
                                },
                                "@author-instance-id": "2017657573-9edd318438ba1898a6ef51bef7fa9bf3",
                                "@seq": "8",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Eismant",
                                "@auid": "57472267500",
                                "ce:indexed-name": "Eismant A."
                            },
                            {
                                "ce:given-name": "Frankis",
                                "preferred-name": {
                                    "ce:given-name": "Frankis",
                                    "ce:initials": "F.",
                                    "ce:surname": "Almaguel",
                                    "ce:indexed-name": "Almaguel F."
                                },
                                "@author-instance-id": "2017657573-c64b421e8fd46bb98c2a83a51e8cd73f",
                                "@seq": "9",
                                "ce:initials": "F.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Almaguel",
                                "@auid": "23988654600",
                                "ce:indexed-name": "Almaguel F."
                            },
                            {
                                "ce:given-name": "Harshad R.",
                                "preferred-name": {
                                    "ce:given-name": "Harshad R.",
                                    "ce:initials": "H.R.",
                                    "ce:surname": "Kulkarni",
                                    "ce:indexed-name": "Kulkarni H.R."
                                },
                                "@author-instance-id": "2017657573-873772eff76e497c0ae1f80520733a7d",
                                "@seq": "15",
                                "ce:initials": "H.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kulkarni",
                                "@auid": "47161378700",
                                "ce:indexed-name": "Kulkarni H.R."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "125045767",
                            "@country": "deu",
                            "city": "Wiesbaden",
                            "organization": [
                                {"$": "Curanosticum Wiesbaden-Frankfurt"},
                                {"$": "Center for Advanced Radiomolecular Precision Oncology"}
                            ],
                            "affiliation-id": {
                                "@afid": "125045767",
                                "@dptid": "127990003"
                            },
                            "@affiliation-instance-id": "2017657573-ad397e02748030974d59dca329640130",
                            "ce:source-text": "Curanosticum Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany",
                            "@dptid": "127990003"
                        },
                        "author": [{
                            "ce:given-name": "Richard P.",
                            "preferred-name": {
                                "ce:given-name": "Richard P.",
                                "ce:initials": "R.P.",
                                "ce:surname": "Baum",
                                "ce:indexed-name": "Baum R.P."
                            },
                            "@author-instance-id": "2017657573-6caea5b81c36601baba006db90197893",
                            "@seq": "1",
                            "ce:initials": "R.P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Baum",
                            "@auid": "55579753600",
                            "ce:indexed-name": "Baum R.P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "104425653"
                                },
                                {"@afid": "60022183"}
                            ],
                            "@affiliation-instance-id": "2017657573-44a8129678d359c4c035876d320fd8a0",
                            "ce:source-text": "Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "104425653"
                        },
                        "author": [{
                            "ce:given-name": "Maythinee",
                            "preferred-name": {
                                "ce:given-name": "Maythinee",
                                "ce:initials": "M.",
                                "ce:surname": "Chantadisai",
                                "ce:indexed-name": "Chantadisai M."
                            },
                            "@author-instance-id": "2017657573-6bc70175e7a487cb78329aaf3ecd9fc1",
                            "@seq": "4",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chantadisai",
                            "@auid": "56183484200",
                            "ce:indexed-name": "Chantadisai M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60026680",
                            "@country": "sgp",
                            "city": "Singapore",
                            "organization": [
                                {"$": "Yong Loo Lin School of Medicine"},
                                {"$": "National University of Singapore"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60026680"},
                                {"@afid": "60017161"}
                            ],
                            "@affiliation-instance-id": "2017657573-1382e1e251852551ea8f0dc783b2ad6b",
                            "ce:source-text": "Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"
                        },
                        "author": [{
                            "ce:given-name": "Jingjing",
                            "preferred-name": {
                                "ce:given-name": "Jingjing",
                                "ce:initials": "J.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang J."
                            },
                            "@author-instance-id": "2017657573-2a97a5a0d7dc3db5d84705500dd9aa19",
                            "@seq": "6",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zhang",
                            "@auid": "55565946700",
                            "ce:indexed-name": "Zhang J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60113483",
                            "@country": "usa",
                            "city": "Loma Linda",
                            "organization": {"$": "Loma Linda University"},
                            "affiliation-id": {"@afid": "60113483"},
                            "state": "CA",
                            "@affiliation-instance-id": "2017657573-3cbb436ca9bc8c58b7d6ed9e7f311ce5",
                            "ce:source-text": "Loma Linda University, Loma Linda, California"
                        },
                        "author": [{
                            "ce:given-name": "Frankis",
                            "preferred-name": {
                                "ce:given-name": "Frankis",
                                "ce:initials": "F.",
                                "ce:surname": "Almaguel",
                                "ce:indexed-name": "Almaguel F."
                            },
                            "@author-instance-id": "2017657573-c64b421e8fd46bb98c2a83a51e8cd73f",
                            "@seq": "9",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Almaguel",
                            "@auid": "23988654600",
                            "ce:indexed-name": "Almaguel F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "109577531",
                            "@country": "deu",
                            "city": "Berlin",
                            "organization": {"$": "3B Pharmaceuticals GmbH"},
                            "affiliation-id": {"@afid": "109577531"},
                            "@affiliation-instance-id": "2017657573-cf00ca9c88a17e7d4beda14ad69c1662",
                            "ce:source-text": "B Pharmaceuticals GmbH, Berlin, Germany"
                        },
                        "author": [
                            {
                                "ce:given-name": "Dirk",
                                "preferred-name": {
                                    "ce:given-name": "Dirk",
                                    "ce:initials": "D.",
                                    "ce:surname": "Zboralski",
                                    "ce:indexed-name": "Zboralski D."
                                },
                                "@author-instance-id": "2017657573-b546907fd7956694daa513a76ac7c75e",
                                "@seq": "10",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Zboralski",
                                "@auid": "24823104700",
                                "ce:indexed-name": "Zboralski D."
                            },
                            {
                                "ce:given-name": "Frank",
                                "preferred-name": {
                                    "ce:given-name": "Frank",
                                    "ce:initials": "F.",
                                    "ce:surname": "Osterkamp",
                                    "ce:indexed-name": "Osterkamp F."
                                },
                                "@author-instance-id": "2017657573-2ebc987ce9d8d676e6e043f779ca7d60",
                                "@seq": "11",
                                "ce:initials": "F.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Osterkamp",
                                "@auid": "6506656940",
                                "ce:indexed-name": "Osterkamp F."
                            },
                            {
                                "ce:given-name": "Aileen",
                                "preferred-name": {
                                    "ce:given-name": "Aileen",
                                    "ce:initials": "A.",
                                    "ce:surname": "Hoehne",
                                    "ce:indexed-name": "Hoehne A."
                                },
                                "@author-instance-id": "2017657573-dcb443f1e8aaae2b18a989386bdfa1ac",
                                "@seq": "12",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Hoehne",
                                "@auid": "55359055300",
                                "ce:indexed-name": "Hoehne A."
                            },
                            {
                                "ce:given-name": "Ulrich",
                                "preferred-name": {
                                    "ce:given-name": "Ulrich",
                                    "ce:initials": "U.",
                                    "ce:surname": "Reineke",
                                    "ce:indexed-name": "Reineke U."
                                },
                                "@author-instance-id": "2017657573-fcf26de660938ad03e950f1640239b40",
                                "@seq": "13",
                                "ce:initials": "U.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Reineke",
                                "@auid": "6701675986",
                                "ce:indexed-name": "Reineke U."
                            },
                            {
                                "ce:given-name": "Christiane",
                                "preferred-name": {
                                    "ce:given-name": "Christiane",
                                    "ce:initials": "C.",
                                    "ce:surname": "Smerling",
                                    "ce:indexed-name": "Smerling C."
                                },
                                "@author-instance-id": "2017657573-9dc3adf8403d0360c61e11ce9d000ead",
                                "@seq": "14",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Smerling",
                                "@auid": "17435698600",
                                "ce:indexed-name": "Smerling C."
                            }
                        ]
                    }
                ],
                "citation-title": "Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results",
                "abstracts": "© 2022 by the Society of Nuclear Medicine andMolecular Imaging.Fibroblast activation protein (FAP) is a promising target for diagnosis and therapy of numerous malignant tumors. FAP-2286 is the conjugate of a FAP-binding peptide, which can be labeled with radionuclides for theranostic applications. We present the first-in-humans results using 177Lu-FAP-2286 for peptide-targeted radionuclide therapy (PTRT). Methods: PTRT using 177Lu-FAP-2286 was performed on 11 patients with advanced adenocarcinomas of the pancreas, breast, rectum, or ovary after prior confirmation of uptake on 68Ga-FAP-2286 or 68Ga- FAPI-04 PET/CT. Results: Administration of 177Lu-FAP-2286 (5.8 6 2.0 GBq; range, 2.4-9.9 GBq) was well tolerated, with no adverse symptoms or clinically detectable pharmacologic effects being noticed or reported in any of the patients. The whole-body effective dose was 0.07 6 0.02 Gy/GBq (range, 0.04-0.1 Gy/GBq). The mean absorbed doses for kidneys and red marrow were 1.0 6 0.6 Gy/GBq (range, 0.4-2.0 Gy/GBq) and 0.05 6 0.02 Gy/GBq (range, 0.03-0.09 Gy/GBq), respectively. Significant uptake and long tumor retention of 177Lu-FAP- 2286 resulted in high absorbed tumor doses, such as 3.0 6 2.7 Gy/ GBq (range, 0.5-10.6 Gy/GBq) in bone metastases. No grade 4 adverse events were observed. Grade 3 events occurred in 3 patients-1 with pancytopenia, 1 with leukocytopenia, and 1 with pain flare-up; 3 patients reported a pain response. Conclusion: 177Lu-FAP- 2286 PTRT, applied in a broad spectrum of cancers, was relatively well tolerated, with acceptable side effects, and demonstrated long retention of the radiopeptide. Prospective clinical studies are warranted.",
                "correspondence": {
                    "affiliation": {
                        "country": "Germany",
                        "@country": "deu",
                        "city": "Bad Berka",
                        "organization": [
                            {"$": "Theranostics Center for Molecular Radiotherapy and Molecular Imaging"},
                            {"$": "Zentralklinik Bad Berka"}
                        ],
                        "ce:source-text": "Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany"
                    },
                    "person": {
                        "ce:given-name": "Harshad R.",
                        "ce:initials": "H.R.",
                        "ce:surname": "Kulkarni",
                        "ce:indexed-name": "Kulkarni H.R."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "177Lu-FAP-2286",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "adenocarcinoma",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "fibroblast activation protein",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "first-in-humans",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "peptidetargeted radionuclide therapy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.120.259192",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Nuclear Medicine",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "63",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "415",
                            "@last": "423"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Nuclear Medicine",
                    "publicationdate": {
                        "month": "03",
                        "year": "2022",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 March 2022"
                        },
                        "day": "01"
                    },
                    "codencode": "JNMEA",
                    "sourcetitle-abbrev": "J. Nucl. Med.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "2159662X",
                            "@type": "electronic"
                        },
                        {
                            "$": "01615505",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Society of Nuclear Medicine Inc."},
                    "@srcid": "17230"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "14",
                                    "classification-description": "Radiology"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2741"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": {
                                "cas-registry-number": [
                                    {"$": "7440-55-3"},
                                    {"$": "14391-02-7"}
                                ],
                                "chemical-name": "gallium"
                            }
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Gallium Radioisotopes"},
                                {"chemical-name": "Peptides"},
                                {"chemical-name": "Radioisotopes"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "10",
                    "@timestamp": "BST 13:24:07",
                    "@year": "2022",
                    "@month": "06"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2017657573",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "635453359",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "939720710",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220345806",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "34168013",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20221230453",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20221352071",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20229007341921",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85125553283",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85125553283",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "635453359",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76462999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.2967/jnumed.120.259192"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "31",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 2017; 10:76.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The role of stromal cancer-associated fibroblasts in pancreatic cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85016253764",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "76"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "von Ahrens",
                                    "ce:indexed-name": "von Ahrens D"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "TD",
                                    "@_fa": "true",
                                    "ce:surname": "Bhagat",
                                    "ce:indexed-name": "Bhagat TD"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Nagrath",
                                    "ce:indexed-name": "Nagrath D"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Maitra",
                                    "ce:indexed-name": "Maitra A"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Verma",
                                    "ce:indexed-name": "Verma A."
                                }
                            ]},
                            "ref-sourcetitle": "J Hematol Oncol"
                        },
                        "ce:source-text": "von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 2017; 10:76."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Rønnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996; 76:69-125.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1996"},
                            "ref-title": {"ref-titletext": "Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0030051051",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "76"},
                                "pagerange": {
                                    "@first": "69",
                                    "@last": "125"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Rønnov-Jessen",
                                    "ce:indexed-name": "Ronnov-Jessen L"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "OW",
                                    "@_fa": "true",
                                    "ce:surname": "Petersen",
                                    "ce:indexed-name": "Petersen OW"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Bissell",
                                    "ce:indexed-name": "Bissell MJ."
                                }
                            ]},
                            "ref-sourcetitle": "Physiol Rev"
                        },
                        "ce:source-text": "Rønnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996; 76:69-125."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H. Cancer-associated fibroblasts: their characteristics and their roles in tumor growth. Cancers (Basel). 2015; 7:2443-2458.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Cancer-associated fibroblasts: their characteristics and their roles in tumor growth"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84949775551",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "2443",
                                    "@last": "2458"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Shiga",
                                    "ce:indexed-name": "Shiga K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Hara",
                                    "ce:indexed-name": "Hara M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Nagasaki",
                                    "ce:indexed-name": "Nagasaki T"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Sato",
                                    "ce:indexed-name": "Sato T"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Takahashi",
                                    "ce:indexed-name": "Takahashi H"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Takeyama",
                                    "ce:indexed-name": "Takeyama H."
                                }
                            ]},
                            "ref-sourcetitle": "Cancers (Basel)"
                        },
                        "ce:source-text": "Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H. Cancer-associated fibroblasts: their characteristics and their roles in tumor growth. Cancers (Basel). 2015; 7:2443-2458."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 1990; 87:7235-7239.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1990"},
                            "ref-title": {"ref-titletext": "Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0025083528",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "87"},
                                "pagerange": {
                                    "@first": "7235",
                                    "@last": "7239"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Garin-Chesa",
                                    "ce:indexed-name": "Garin-Chesa P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "LJ",
                                    "@_fa": "true",
                                    "ce:surname": "Old",
                                    "ce:indexed-name": "Old LJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "WJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Rettig",
                                    "ce:indexed-name": "Rettig WJ."
                                }
                            ]},
                            "ref-sourcetitle": "Proc Natl Acad Sci USA"
                        },
                        "ce:source-text": "Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 1990; 87:7235-7239."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Pure E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018; 37:4343-4357.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046337806",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "4343",
                                    "@last": "4357"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Pure",
                                    "ce:indexed-name": "Pure E"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Blomberg",
                                    "ce:indexed-name": "Blomberg R."
                                }
                            ]},
                            "ref-sourcetitle": "Oncogene"
                        },
                        "ce:source-text": "Pure E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018; 37:4343-4357."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Schuberth PC, Hagedorn C, Jensen SM, et al. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. J Transl Med. 2013; 11:187.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84882636722",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "187"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PC",
                                        "@_fa": "true",
                                        "ce:surname": "Schuberth",
                                        "ce:indexed-name": "Schuberth PC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Hagedorn",
                                        "ce:indexed-name": "Hagedorn C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Jensen",
                                        "ce:indexed-name": "Jensen SM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Transl Med"
                        },
                        "ce:source-text": "Schuberth PC, Hagedorn C, Jensen SM, et al. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. J Transl Med. 2013; 11:187."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Bauer S, Jendro MC, Wadle A, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006; 8:R171.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "70350542778",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "R171"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Bauer",
                                        "ce:indexed-name": "Bauer S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MC",
                                        "@_fa": "true",
                                        "ce:surname": "Jendro",
                                        "ce:indexed-name": "Jendro MC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Wadle",
                                        "ce:indexed-name": "Wadle A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Arthritis Res Ther"
                        },
                        "ce:source-text": "Bauer S, Jendro MC, Wadle A, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006; 8:R171."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Varasteh Z, Mohanta S, Robu S, et al. Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med. 2019; 60:1743-1749.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85074974348",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "1743",
                                    "@last": "1749"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Varasteh",
                                        "ce:indexed-name": "Varasteh Z"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Mohanta",
                                        "ce:indexed-name": "Mohanta S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Robu",
                                        "ce:indexed-name": "Robu S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Varasteh Z, Mohanta S, Robu S, et al. Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med. 2019; 60:1743-1749."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Hofheinz RD, al-Batran SE, Hartmann F, et al. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003; 26:44-48.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037219532",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "44",
                                    "@last": "48"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RD",
                                        "@_fa": "true",
                                        "ce:surname": "Hofheinz",
                                        "ce:indexed-name": "Hofheinz RD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "al-Batran",
                                        "ce:indexed-name": "al-Batran SE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Hartmann",
                                        "ce:indexed-name": "Hartmann F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Onkologie"
                        },
                        "ce:source-text": "Hofheinz RD, al-Batran SE, Hartmann F, et al. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003; 26:44-48."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Scott AM, Wiseman G, Welt S, et al. A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003; 9:1639-1647.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037989982",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "1639",
                                    "@last": "1647"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Scott",
                                        "ce:indexed-name": "Scott AM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Wiseman",
                                        "ce:indexed-name": "Wiseman G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Welt",
                                        "ce:indexed-name": "Welt S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Scott AM, Wiseman G, Welt S, et al. A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003; 9:1639-1647."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Br\u20acunker P, Wartha K, Friess T, et al. RG7386, a novel tetravalent FAP-DR5 antibody, effectively triggers FAP-dependent, avidity-driven DR5 hyperclustering and tumor cell apoptosis. Mol Cancer Ther. 2016; 15:946-957.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "RG7386, a novel tetravalent FAP-DR5 antibody, effectively triggers FAP-dependent, avidity-driven DR5 hyperclustering and tumor cell apoptosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84969540602",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "946",
                                    "@last": "957"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Br\u20acunker",
                                        "ce:indexed-name": "Br\u20acunker P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Wartha",
                                        "ce:indexed-name": "Wartha K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Friess",
                                        "ce:indexed-name": "Friess T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol Cancer Ther"
                        },
                        "ce:source-text": "Br\u20acunker P, Wartha K, Friess T, et al. RG7386, a novel tetravalent FAP-DR5 antibody, effectively triggers FAP-dependent, avidity-driven DR5 hyperclustering and tumor cell apoptosis. Mol Cancer Ther. 2016; 15:946-957."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Fabre M, Ferrer C, Dominguez-Hormaetxe S, et al. OMTX705, a novel FAPtargeting ADC demonstrates activity in chemotherapy and pembrolizumabresistant solid tumor models. Clin Cancer Res. 2020; 26:3420-3430.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "OMTX705, a novel FAPtargeting ADC demonstrates activity in chemotherapy and pembrolizumabresistant solid tumor models"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85087470110",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "3420",
                                    "@last": "3430"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Fabre",
                                        "ce:indexed-name": "Fabre M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrer",
                                        "ce:indexed-name": "Ferrer C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Dominguez-Hormaetxe",
                                        "ce:indexed-name": "Dominguez-Hormaetxe S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Fabre M, Ferrer C, Dominguez-Hormaetxe S, et al. OMTX705, a novel FAPtargeting ADC demonstrates activity in chemotherapy and pembrolizumabresistant solid tumor models. Clin Cancer Res. 2020; 26:3420-3430."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Jansen K, Heirbaut L, Cheng JD, et al. Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold. ACS Med Chem Lett. 2013; 4:491-496.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84877712854",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "491",
                                    "@last": "496"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Jansen",
                                        "ce:indexed-name": "Jansen K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Heirbaut",
                                        "ce:indexed-name": "Heirbaut L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JD",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng JD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ACS Med Chem Lett"
                        },
                        "ce:source-text": "Jansen K, Heirbaut L, Cheng JD, et al. Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold. ACS Med Chem Lett. 2013; 4:491-496."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lindner T, Loktev A, Altmann A, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018; 59: 1415-1422.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85052145670",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "1415",
                                    "@last": "1422"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Lindner",
                                        "ce:indexed-name": "Lindner T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Loktev",
                                        "ce:indexed-name": "Loktev A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Altmann",
                                        "ce:indexed-name": "Altmann A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Lindner T, Loktev A, Altmann A, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018; 59: 1415-1422."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Osterkamp F, Zboralski D, Schneider E, et al., inventors. 3B Pharmaceuticals GmbH, assignee. Compounds comprising a fibroblast activation protein ligand and use thereof. Patent WO2021005125. January 14, 2021.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85119041838",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "inventors. 3B Pharmaceuticals GmbH, assignee. Patent WO2021005125. January 14",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Osterkamp",
                                        "ce:indexed-name": "Osterkamp F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Zboralski",
                                        "ce:indexed-name": "Zboralski D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Schneider",
                                        "ce:indexed-name": "Schneider E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Compounds comprising a fibroblast activation protein ligand and use thereof"
                        },
                        "ce:source-text": "Osterkamp F, Zboralski D, Schneider E, et al., inventors. 3B Pharmaceuticals GmbH, assignee. Compounds comprising a fibroblast activation protein ligand and use thereof. Patent WO2021005125. January 14, 2021."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Zboralski D, Osterkamp F, Simmons AD, et al. Preclinical evaluation of FAP-2286. a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP) [abstract]. Ann Oncol. 2020; 31(suppl 4):S488.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Preclinical evaluation of FAP-2286. a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP) [abstract]"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85115900377",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {"@first": "S488"}
                            },
                            "ref-text": "(suppl 4)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Zboralski",
                                        "ce:indexed-name": "Zboralski D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Osterkamp",
                                        "ce:indexed-name": "Osterkamp F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AD",
                                        "@_fa": "true",
                                        "ce:surname": "Simmons",
                                        "ce:indexed-name": "Simmons AD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Zboralski D, Osterkamp F, Simmons AD, et al. Preclinical evaluation of FAP-2286. a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP) [abstract]. Ann Oncol. 2020; 31(suppl 4):S488."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Mueller D, Breeman WA, Klette I, et al. Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method. Nat Protoc. 2016; 11:1057-1066.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84971320796",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "1057",
                                    "@last": "1066"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Mueller",
                                        "ce:indexed-name": "Mueller D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WA",
                                        "@_fa": "true",
                                        "ce:surname": "Breeman",
                                        "ce:indexed-name": "Breeman WA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Klette",
                                        "ce:indexed-name": "Klette I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Protoc"
                        },
                        "ce:source-text": "Mueller D, Breeman WA, Klette I, et al. Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method. Nat Protoc. 2016; 11:1057-1066."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Schultz MK, Mueller D, Baum RP, Leonard Watkins G, Breeman WA. A new automated NaCl based robust method for routine production of gallium-68 labeled peptides. Appl Radiat Isot. 2013; 76:46-54.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "A new automated NaCl based robust method for routine production of gallium-68 labeled peptides"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84878162429",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "76"},
                                "pagerange": {
                                    "@first": "46",
                                    "@last": "54"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MK",
                                    "@_fa": "true",
                                    "ce:surname": "Schultz",
                                    "ce:indexed-name": "Schultz MK"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Mueller",
                                    "ce:indexed-name": "Mueller D"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "RP",
                                    "@_fa": "true",
                                    "ce:surname": "Baum",
                                    "ce:indexed-name": "Baum RP"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Leonard Watkins",
                                    "ce:indexed-name": "Leonard Watkins G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "WA.",
                                    "@_fa": "true",
                                    "ce:surname": "Breeman",
                                    "ce:indexed-name": "Breeman WA."
                                }
                            ]},
                            "ref-sourcetitle": "Appl Radiat Isot"
                        },
                        "ce:source-text": "Schultz MK, Mueller D, Baum RP, Leonard Watkins G, Breeman WA. A new automated NaCl based robust method for routine production of gallium-68 labeled peptides. Appl Radiat Isot. 2013; 76:46-54."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Mueller D, Fuchs A, Leshch Y, et al. Radiolabeling and stability of FAP-seeking radiopharmaceuticals for radio-molecular imaging and therapy [abstract]. J Nucl Med. 2020; 61(suppl 1):1129.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Radiolabeling and stability of FAP-seeking radiopharmaceuticals for radio-molecular imaging and therapy [abstract]"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85128285588",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {"@first": "1129"}
                            },
                            "ref-text": "(suppl 1)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Mueller",
                                        "ce:indexed-name": "Mueller D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Fuchs",
                                        "ce:indexed-name": "Fuchs A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Leshch",
                                        "ce:indexed-name": "Leshch Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Nucl Med"
                        },
                        "ce:source-text": "Mueller D, Fuchs A, Leshch Y, et al. Radiolabeling and stability of FAP-seeking radiopharmaceuticals for radio-molecular imaging and therapy [abstract]. J Nucl Med. 2020; 61(suppl 1):1129."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Common Terminology Criteria for Adverse Events (CTCAE): version 5.0. National Cancer Institute website. https://ctep.cancer.gov/protocoldevelopment/ electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. Published November 27, 2017. Accessed November 9, 2021.",
                        "@id": "20",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "12344312699",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "National Cancer Institute website. Published November 27, 2017. Accessed November 9, 2021",
                            "ref-sourcetitle": "Common Terminology Criteria for Adverse Events (CTCAE): version 5.0"
                        },
                        "ce:source-text": "Common Terminology Criteria for Adverse Events (CTCAE): version 5.0. National Cancer Institute website. https://ctep.cancer.gov/protocoldevelopment/ electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. Published November 27, 2017. Accessed November 9, 2021."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Schuchardt C, Kulkarni HR, Prasad V, Zachert C, Muller D, Baum RP. The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using 177Lu-DOTATATE, 177Lu-DOTANOC, and 177Lu-DOTATOC. Recent Results Cancer Res. 2013; 194:519-536.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using 177Lu-DOTATATE, 177Lu-DOTANOC, and 177Lu-DOTATOC"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867048375",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "194"},
                                "pagerange": {
                                    "@first": "519",
                                    "@last": "536"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Schuchardt",
                                    "ce:indexed-name": "Schuchardt C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "HR",
                                    "@_fa": "true",
                                    "ce:surname": "Kulkarni",
                                    "ce:indexed-name": "Kulkarni HR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V",
                                    "@_fa": "true",
                                    "ce:surname": "Prasad",
                                    "ce:indexed-name": "Prasad V"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Zachert",
                                    "ce:indexed-name": "Zachert C"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Muller",
                                    "ce:indexed-name": "Muller D"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "RP.",
                                    "@_fa": "true",
                                    "ce:surname": "Baum",
                                    "ce:indexed-name": "Baum RP."
                                }
                            ]},
                            "ref-sourcetitle": "Recent Results Cancer Res"
                        },
                        "ce:source-text": "Schuchardt C, Kulkarni HR, Prasad V, Zachert C, Muller D, Baum RP. The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using 177Lu-DOTATATE, 177Lu-DOTANOC, and 177Lu-DOTATOC. Recent Results Cancer Res. 2013; 194:519-536."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kratochwil C, Flechsig P, Lindner T, et al. 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J NuclMed. 2019; 60:801-805.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85066890000",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "801",
                                    "@last": "805"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Kratochwil",
                                        "ce:indexed-name": "Kratochwil C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Flechsig",
                                        "ce:indexed-name": "Flechsig P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Lindner",
                                        "ce:indexed-name": "Lindner T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J NuclMed"
                        },
                        "ce:source-text": "Kratochwil C, Flechsig P, Lindner T, et al. 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J NuclMed. 2019; 60:801-805."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl JMed. 2017; 376:125-135.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85009286837",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "376"},
                                "pagerange": {
                                    "@first": "125",
                                    "@last": "135"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Strosberg",
                                        "ce:indexed-name": "Strosberg J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "El-Haddad",
                                        "ce:indexed-name": "El-Haddad G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Wolin",
                                        "ce:indexed-name": "Wolin E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl JMed"
                        },
                        "ce:source-text": "Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl JMed. 2017; 376:125-135."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Hofman MS, Violet J, Hicks RJ, et al. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol. 2018; 19:825-833.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046797112",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "825",
                                    "@last": "833"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MS",
                                        "@_fa": "true",
                                        "ce:surname": "Hofman",
                                        "ce:indexed-name": "Hofman MS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Violet",
                                        "ce:indexed-name": "Violet J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RJ",
                                        "@_fa": "true",
                                        "ce:surname": "Hicks",
                                        "ce:indexed-name": "Hicks RJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Hofman MS, Violet J, Hicks RJ, et al. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol. 2018; 19:825-833."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kulkarni HR, Singh A, Schuchardt C, et al. PSMA-based radioligand therapy for metastatic castration-resistant prostate cancer: the Bad Berka experience since 2013. J NuclMed. 2016; 57(suppl):97S-104S.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "PSMA-based radioligand therapy for metastatic castration-resistant prostate cancer: the Bad Berka experience since 2013"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84991320867",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "57"},
                                "pagerange": {
                                    "@first": "97S",
                                    "@last": "104S"
                                }
                            },
                            "ref-text": "(suppl)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HR",
                                        "@_fa": "true",
                                        "ce:surname": "Kulkarni",
                                        "ce:indexed-name": "Kulkarni HR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Singh",
                                        "ce:indexed-name": "Singh A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Schuchardt",
                                        "ce:indexed-name": "Schuchardt C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J NuclMed"
                        },
                        "ce:source-text": "Kulkarni HR, Singh A, Schuchardt C, et al. PSMA-based radioligand therapy for metastatic castration-resistant prostate cancer: the Bad Berka experience since 2013. J NuclMed. 2016; 57(suppl):97S-104S."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Wehrmann C, Senftleben S, Zachert C, Muller D, Baum RP. Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC. Cancer Biother Radiopharm. 2007; 22: 406-416.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34447527563",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "406",
                                    "@last": "416"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Wehrmann",
                                    "ce:indexed-name": "Wehrmann C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Senftleben",
                                    "ce:indexed-name": "Senftleben S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Zachert",
                                    "ce:indexed-name": "Zachert C"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Muller",
                                    "ce:indexed-name": "Muller D"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "RP.",
                                    "@_fa": "true",
                                    "ce:surname": "Baum",
                                    "ce:indexed-name": "Baum RP."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Biother Radiopharm"
                        },
                        "ce:source-text": "Wehrmann C, Senftleben S, Zachert C, Muller D, Baum RP. Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC. Cancer Biother Radiopharm. 2007; 22: 406-416."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yadav MP, Ballal S, Tripathi M, et al. Post-therapeutic dosimetry of 177Lu-DKFZPSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer. Nucl Med Commun. 2017; 38:91-98.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Post-therapeutic dosimetry of 177Lu-DKFZPSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84992378395",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "91",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Yadav",
                                        "ce:indexed-name": "Yadav MP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ballal",
                                        "ce:indexed-name": "Ballal S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Tripathi",
                                        "ce:indexed-name": "Tripathi M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nucl Med Commun"
                        },
                        "ce:source-text": "Yadav MP, Ballal S, Tripathi M, et al. Post-therapeutic dosimetry of 177Lu-DKFZPSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer. Nucl Med Commun. 2017; 38:91-98."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Violet J, Jackson P, Ferdinandus J, et al. Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes.JNuclMed. 2019; 60:517-523.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85063094373",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "517",
                                    "@last": "523"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Violet",
                                        "ce:indexed-name": "Violet J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Jackson",
                                        "ce:indexed-name": "Jackson P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Ferdinandus",
                                        "ce:indexed-name": "Ferdinandus J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JNuclMed"
                        },
                        "ce:source-text": "Violet J, Jackson P, Ferdinandus J, et al. Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes.JNuclMed. 2019; 60:517-523."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Sabet A, Khalaf F, Mahjoob S, et al. May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET?. A pilot report on 188Re-HEDP treatment in progressive bone metastases after 177Lu-octreotate. Am J Nucl Med Mol Imaging. 2013; 4:80-88.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET?. A pilot report on 188Re-HEDP treatment in progressive bone metastases after 177Lu-octreotate"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019159462",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "80",
                                    "@last": "88"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Sabet",
                                        "ce:indexed-name": "Sabet A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Khalaf",
                                        "ce:indexed-name": "Khalaf F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Mahjoob",
                                        "ce:indexed-name": "Mahjoob S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Nucl Med Mol Imaging"
                        },
                        "ce:source-text": "Sabet A, Khalaf F, Mahjoob S, et al. May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET?. A pilot report on 188Re-HEDP treatment in progressive bone metastases after 177Lu-octreotate. Am J Nucl Med Mol Imaging. 2013; 4:80-88."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Graf F, Fahrer J, Maus S, et al. DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy. PLoS One. 2014; 9:e88239.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84895763591",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "e88239"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Graf",
                                        "ce:indexed-name": "Graf F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fahrer",
                                        "ce:indexed-name": "Fahrer J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Maus",
                                        "ce:indexed-name": "Maus S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Graf F, Fahrer J, Maus S, et al. DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy. PLoS One. 2014; 9:e88239."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Watabe T, Liu Y, Kaneda-Nakashima K, et al. Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu- and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models. J NuclMed. 2020; 61:563-569.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu- and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85082805870",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "563",
                                    "@last": "569"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Watabe",
                                        "ce:indexed-name": "Watabe T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Kaneda-Nakashima",
                                        "ce:indexed-name": "Kaneda-Nakashima K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J NuclMed"
                        },
                        "ce:source-text": "Watabe T, Liu Y, Kaneda-Nakashima K, et al. Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu- and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models. J NuclMed. 2020; 61:563-569."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Loma Linda",
            "@id": "60113483",
            "affilname": "Loma Linda University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60113483",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60026680",
            "affilname": "NUS Yong Loo Lin School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026680",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Berga",
            "@id": "60018973",
            "affilname": "Zentralklinik Bad Berka",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Wiesbaden",
            "@id": "125045767",
            "affilname": "Center for Advanced Radiomolecular Precision Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125045767",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Berlin",
            "@id": "109577531",
            "affilname": "3B Pharmaceuticals GmbH",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109577531",
            "affiliation-country": "Germany"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85125553283",
        "dc:description": "Fibroblast activation protein (FAP) is a promising target for diagnosis and therapy of numerous malignant tumors. FAP-2286 is the conjugate of a FAP-binding peptide, which can be labeled with radionuclides for theranostic applications. We present the first-in-humans results using 177Lu-FAP-2286 for peptide-targeted radionuclide therapy (PTRT). Methods: PTRT using 177Lu-FAP-2286 was performed on 11 patients with advanced adenocarcinomas of the pancreas, breast, rectum, or ovary after prior confirmation of uptake on 68Ga-FAP-2286 or 68Ga- FAPI-04 PET/CT. Results: Administration of 177Lu-FAP-2286 (5.8 6 2.0 GBq; range, 2.4-9.9 GBq) was well tolerated, with no adverse symptoms or clinically detectable pharmacologic effects being noticed or reported in any of the patients. The whole-body effective dose was 0.07 6 0.02 Gy/GBq (range, 0.04-0.1 Gy/GBq). The mean absorbed doses for kidneys and red marrow were 1.0 6 0.6 Gy/GBq (range, 0.4-2.0 Gy/GBq) and 0.05 6 0.02 Gy/GBq (range, 0.03-0.09 Gy/GBq), respectively. Significant uptake and long tumor retention of 177Lu-FAP- 2286 resulted in high absorbed tumor doses, such as 3.0 6 2.7 Gy/ GBq (range, 0.5-10.6 Gy/GBq) in bone metastases. No grade 4 adverse events were observed. Grade 3 events occurred in 3 patients-1 with pancytopenia, 1 with leukocytopenia, and 1 with pain flare-up; 3 patients reported a pain response. Conclusion: 177Lu-FAP- 2286 PTRT, applied in a broad spectrum of cancers, was relatively well tolerated, with acceptable side effects, and demonstrated long retention of the radiopeptide. Prospective clinical studies are warranted.",
        "pubmed-id": "34168013",
        "prism:coverDate": "2022-03-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85125553283",
        "dc:creator": {"author": [{
            "ce:given-name": "Richard P.",
            "preferred-name": {
                "ce:given-name": "Richard P.",
                "ce:initials": "R.P.",
                "ce:surname": "Baum",
                "ce:indexed-name": "Baum R.P."
            },
            "@seq": "1",
            "ce:initials": "R.P.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60018973",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
                },
                {
                    "@id": "125045767",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125045767"
                }
            ],
            "ce:surname": "Baum",
            "@auid": "55579753600",
            "author-url": "https://api.elsevier.com/content/author/author_id/55579753600",
            "ce:indexed-name": "Baum R.P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85125553283"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85125553283&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85125553283&origin=inward"
            }
        ],
        "source-id": "17230",
        "citedby-count": "79",
        "prism:volume": "63",
        "subtype": "ar",
        "dc:title": "Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results",
        "openaccess": "1",
        "prism:issn": "2159662X 01615505",
        "publishercopyright": "© 2022 by the Society of Nuclear Medicine andMolecular Imaging.",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Nuclear Medicine",
        "prism:pageRange": "415-423",
        "prism:endingPage": "423",
        "openaccessFlag": "true",
        "prism:doi": "10.2967/jnumed.120.259192",
        "prism:startingPage": "415",
        "dc:identifier": "SCOPUS_ID:85125553283",
        "dc:publisher": "Society of Nuclear Medicine Inc."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adenocarcinoma",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Feasibility Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gallium Radioisotopes",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Peptides",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Positron Emission Tomography Computed Tomography",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Prospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Radioisotopes",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Tissue Distribution",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "177Lu-FAP-2286"
        },
        {
            "@_fa": "true",
            "$": "adenocarcinoma"
        },
        {
            "@_fa": "true",
            "$": "fibroblast activation protein"
        },
        {
            "@_fa": "true",
            "$": "first-in-humans"
        },
        {
            "@_fa": "true",
            "$": "peptidetargeted radionuclide therapy"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Radiology, Nuclear Medicine and Imaging",
        "@code": "2741",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Richard P.",
            "preferred-name": {
                "ce:given-name": "Richard P.",
                "ce:initials": "R.P.",
                "ce:surname": "Baum",
                "ce:indexed-name": "Baum R.P."
            },
            "@seq": "1",
            "ce:initials": "R.P.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60018973",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
                },
                {
                    "@id": "125045767",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125045767"
                }
            ],
            "ce:surname": "Baum",
            "@auid": "55579753600",
            "author-url": "https://api.elsevier.com/content/author/author_id/55579753600",
            "ce:indexed-name": "Baum R.P."
        },
        {
            "ce:given-name": "Christiane",
            "preferred-name": {
                "ce:given-name": "Christiane",
                "ce:initials": "C.",
                "ce:surname": "Schuchardt",
                "ce:indexed-name": "Schuchardt C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018973",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
            },
            "ce:surname": "Schuchardt",
            "@auid": "16686933700",
            "author-url": "https://api.elsevier.com/content/author/author_id/16686933700",
            "ce:indexed-name": "Schuchardt C."
        },
        {
            "ce:given-name": "Aviral",
            "preferred-name": {
                "ce:given-name": "Aviral",
                "ce:initials": "A.",
                "ce:surname": "Singh",
                "ce:indexed-name": "Singh A."
            },
            "@seq": "3",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018973",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
            },
            "ce:surname": "Singh",
            "@auid": "56576751100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56576751100",
            "ce:indexed-name": "Singh A."
        },
        {
            "ce:given-name": "Maythinee",
            "preferred-name": {
                "ce:given-name": "Maythinee",
                "ce:initials": "M.",
                "ce:surname": "Chantadisai",
                "ce:indexed-name": "Chantadisai M."
            },
            "@seq": "4",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60018973",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Chantadisai",
            "@auid": "56183484200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56183484200",
            "ce:indexed-name": "Chantadisai M."
        },
        {
            "ce:given-name": "Franz C.",
            "preferred-name": {
                "ce:given-name": "Franz C.",
                "ce:initials": "F.C.",
                "ce:surname": "Robiller",
                "ce:indexed-name": "Robiller F.C."
            },
            "@seq": "5",
            "ce:initials": "F.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018973",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
            },
            "ce:surname": "Robiller",
            "@auid": "56182602700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56182602700",
            "ce:indexed-name": "Robiller F.C."
        },
        {
            "ce:given-name": "Jingjing",
            "preferred-name": {
                "ce:given-name": "Jingjing",
                "ce:initials": "J.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang J."
            },
            "@seq": "6",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60018973",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
                },
                {
                    "@id": "60026680",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026680"
                }
            ],
            "ce:surname": "Zhang",
            "@auid": "55565946700",
            "author-url": "https://api.elsevier.com/content/author/author_id/55565946700",
            "ce:indexed-name": "Zhang J."
        },
        {
            "ce:given-name": "Dirk",
            "preferred-name": {
                "ce:given-name": "Dirk",
                "ce:initials": "D.",
                "ce:surname": "Mueller",
                "ce:indexed-name": "Mueller D."
            },
            "@seq": "7",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018973",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
            },
            "ce:surname": "Mueller",
            "@auid": "37054494800",
            "author-url": "https://api.elsevier.com/content/author/author_id/37054494800",
            "ce:indexed-name": "Mueller D."
        },
        {
            "ce:given-name": "Alexander",
            "preferred-name": {
                "ce:given-name": "Alexander",
                "ce:initials": "A.",
                "ce:surname": "Eismant",
                "ce:indexed-name": "Eismant A."
            },
            "@seq": "8",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018973",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
            },
            "ce:surname": "Eismant",
            "@auid": "57472267500",
            "author-url": "https://api.elsevier.com/content/author/author_id/57472267500",
            "ce:indexed-name": "Eismant A."
        },
        {
            "ce:given-name": "Frankis",
            "preferred-name": {
                "ce:given-name": "Frankis",
                "ce:initials": "F.",
                "ce:surname": "Almaguel",
                "ce:indexed-name": "Almaguel F."
            },
            "@seq": "9",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60018973",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
                },
                {
                    "@id": "60113483",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60113483"
                }
            ],
            "ce:surname": "Almaguel",
            "@auid": "23988654600",
            "author-url": "https://api.elsevier.com/content/author/author_id/23988654600",
            "ce:indexed-name": "Almaguel F."
        },
        {
            "ce:given-name": "Dirk",
            "preferred-name": {
                "ce:given-name": "Dirk",
                "ce:initials": "D.",
                "ce:surname": "Zboralski",
                "ce:indexed-name": "Zboralski D."
            },
            "@seq": "10",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "109577531",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109577531"
            },
            "ce:surname": "Zboralski",
            "@auid": "24823104700",
            "author-url": "https://api.elsevier.com/content/author/author_id/24823104700",
            "ce:indexed-name": "Zboralski D."
        },
        {
            "ce:given-name": "Frank",
            "preferred-name": {
                "ce:given-name": "Frank",
                "ce:initials": "F.",
                "ce:surname": "Osterkamp",
                "ce:indexed-name": "Osterkamp F."
            },
            "@seq": "11",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "109577531",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109577531"
            },
            "ce:surname": "Osterkamp",
            "@auid": "6506656940",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506656940",
            "ce:indexed-name": "Osterkamp F."
        },
        {
            "ce:given-name": "Aileen",
            "preferred-name": {
                "ce:given-name": "Aileen",
                "ce:initials": "A.",
                "ce:surname": "Hoehne",
                "ce:indexed-name": "Hoehne A."
            },
            "@seq": "12",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "109577531",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109577531"
            },
            "ce:surname": "Hoehne",
            "@auid": "55359055300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55359055300",
            "ce:indexed-name": "Hoehne A."
        },
        {
            "ce:given-name": "Ulrich",
            "preferred-name": {
                "ce:given-name": "Ulrich",
                "ce:initials": "U.",
                "ce:surname": "Reineke",
                "ce:indexed-name": "Reineke U."
            },
            "@seq": "13",
            "ce:initials": "U.",
            "@_fa": "true",
            "affiliation": {
                "@id": "109577531",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109577531"
            },
            "ce:surname": "Reineke",
            "@auid": "6701675986",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701675986",
            "ce:indexed-name": "Reineke U."
        },
        {
            "ce:given-name": "Christiane",
            "preferred-name": {
                "ce:given-name": "Christiane",
                "ce:initials": "C.",
                "ce:surname": "Smerling",
                "ce:indexed-name": "Smerling C."
            },
            "@seq": "14",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "109577531",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109577531"
            },
            "ce:surname": "Smerling",
            "@auid": "17435698600",
            "author-url": "https://api.elsevier.com/content/author/author_id/17435698600",
            "ce:indexed-name": "Smerling C."
        },
        {
            "ce:given-name": "Harshad R.",
            "preferred-name": {
                "ce:given-name": "Harshad R.",
                "ce:initials": "H.R.",
                "ce:surname": "Kulkarni",
                "ce:indexed-name": "Kulkarni H.R."
            },
            "@seq": "15",
            "ce:initials": "H.R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018973",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018973"
            },
            "ce:surname": "Kulkarni",
            "@auid": "47161378700",
            "author-url": "https://api.elsevier.com/content/author/author_id/47161378700",
            "ce:indexed-name": "Kulkarni H.R."
        }
    ]}
}}